June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Foveal Topographic and Volumetric Measures: New Biomarkers for Detection of Early Glaucoma
Author Affiliations & Notes
  • Melodyanne Y. Cheng
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Vahid Mohammadzadeh
    Jules Stein Eye Institute, Los Angeles, California, United States
  • Sepideh Heydar Zadeh
    Jules Stein Eye Institute, Los Angeles, California, United States
  • Ella Maria Kadas
    Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
    Nocturne GmbH, Germany
  • Sunil Kumar Yadav
    Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
    Nocturne GmbH, Germany
  • Alexander Brandt
    Neurology, University of California Irvine, Irvine, California, United States
  • Kouros Nouri-Mahdavi
    Jules Stein Eye Institute, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Melodyanne Cheng, None; Vahid Mohammadzadeh, None; Sepideh Heydar Zadeh, None; Ella Maria Kadas, Nocturne GmbH (E); Sunil Kumar Yadav, Nocturne GmbH (E); Alexander Brandt, Motognosis GmbH (S), Nocturne GmbH (S); Kouros Nouri-Mahdavi, Heidelberg Engineering (R)
  • Footnotes
    Support  R01 EY029792; Departmental Grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1849. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Melodyanne Y. Cheng, Vahid Mohammadzadeh, Sepideh Heydar Zadeh, Ella Maria Kadas, Sunil Kumar Yadav, Alexander Brandt, Kouros Nouri-Mahdavi; Foveal Topographic and Volumetric Measures: New Biomarkers for Detection of Early Glaucoma. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1849.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To test the hypothesis that newly developed topographic and volumetric foveal outcome measures can discriminate patients with early perimetric glaucoma from normal subjects.

Methods : We used new measures defining inner foveal shape and central macular volume that were recently developed based on parametric modeling of central macula with cubic Bézier (Figure). Global, hemiretinal, and quadrant parameters were calculated for a group of 50 glaucoma eyes (50 patients) with MD of -6 dB or better and 181 eyes of 96 normal subjects. 8×8 arrays of ganglion cell layer (GCL) and inner plexiform layer (IPL) measurements within 3°×3° superpixels were exported and GCIPL thickness parameters were estimated for 5 macular sectors in the superior and inferior hemiretinas. Multivariate logistic regression and area under ROC curves were used to compare the performance of foveal topographic and volumetric measures to that of thickness measurements.

Results : The average (±SD) visual field mean deviation was –3.6 (±1.5) in the glaucoma group. The main global parameters discriminating glaucoma from normal eyes were the macular rim volume and the area of the maximum foveal slope (AUC:0.786). Among the regional topographic/volumetric parameters, a combination of four temporal hemiretinal parameters (rim height, inner rim volume, foveal pit depth, and pit volume) performed best for discrimination of glaucoma from normal eyes (AUC:0.903; 95% CI=0.858-0.948). A combination of 13 regional parameters selected with elastic net regression resulted in AUC of 0.931 (95% CI:0.899-0.966). In comparison, the AUC for the best GCIPL thickness parameter (inferior sector 2) was 0.895 (95% CI:0.844-0.946).

Conclusions : The newly defined topographic and volumetric foveal biomarkers are able to detect early perimetric glaucoma with clinically relevant performance. Such biomarkers do not depend on segmentation of intraretinal layers and may be helpful where adequate segmentation of macular layer cannot be achieved; they may be used to define macular phenotypes in glaucoma and could assist for detection of disease progression in the later stages of glaucoma.

This is a 2021 ARVO Annual Meeting abstract.

 

Description of macular topographic and volumetric measures used in the study. For details see: Yadav SK et al. CuBe: parametric modeling of 3D foveal shape using cubic Bézier. Biomed Opt Express. 2017;8(9):4181-4199.

Description of macular topographic and volumetric measures used in the study. For details see: Yadav SK et al. CuBe: parametric modeling of 3D foveal shape using cubic Bézier. Biomed Opt Express. 2017;8(9):4181-4199.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×